• 1
    Beasley RP, Lin CC, Hwang LY, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 1981; 2: 11291133.
  • 2
    Twu JS, Schloemer RH. Transcriptional trans-activating function of hepatitis B virus. J Virol 1987; 61: 34483453.
  • 3
    Wollersheim M, Debelka U, Hofschneider PH. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 1988; 3: 545552.
  • 4
    Zahm P, Hofschneider PH, Koshy R., The HBV X-ORF encodes a transacti-vator: a potential factor in viral hepatocarcinogenesis. Oncogene 1988; 3: 169177.
  • 5
    Caselmann WH, Meyer M, Kekulé AS, Lauer U, Hofschneider PH, Koshy R. A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc Natl Acad Sci U S A 1990; 87: 29702974.
  • 6
    Kekulé AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH, Koshy R. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional trans activator. Nature 1990; 343: 457461.
  • 7
    Yamamoto S, Nakatake H, Kawamoto M, Koshy R, Matsubara K. Trans-activation of cellular promoters by an integrated hepatitis B virus DNA. Biochem Biophys Res Commun 1993; 192: 111118.
  • 8
    Schlüter V, Meyer M, Hofschneider PH, Koshy R, Caselmann WH. Integrated hepatitis B virus X and 3′ truncated preS/S sequences derived from human hepatomas encode functionally active transactivators. Oncogene 1994; 9: 33353344.
  • 9
    Hildt E, Urban S, Hofschneider PH. Characterization of essential domains for the functionality of the MHBst transcriptional activator and identification of a minimal MHBst activator. Oncogene 1995; 11: 20552066.
  • 10
    Hildt E, Urban S, Lauer U, Hofschneider PH, Kekulé AS. ER-localization and functional expression of the HBV transactivator MHBst. Oncogene 1993; 8: 33593367.
  • 11
    Lauer U, Weiß L, Hofschneider PH, Kekulé AS. The hepatitis B virus preS2/St transactivator is generated by 3′ truncations within a defined region of the S gene. J Virol 1992; 66: 52845289.
  • 12
    Lauer U, Weiß L, Lipp M, Hofschneider PH, Kekulé AS. The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for trans activation. Hepatology 1994; 19: 2331.
  • 13
    Meyer M, Caselmann WH, Schlüter V, Schreck R, Hofschneider PH, Baeuerle PA., Hepatitis B virus transactivator MHBst: activation of NF-kB, selective inhibition by antioxidants and integral membrane localization. EMBO J 1992; 11: 29913001.
  • 14
    Natoll G, Avantaggiati ML, Balsano C, de Marzio E, Collepadro D, Elfassi E, Levrero M. Characterization of the hepatitis B virus preS/S region encoded trans criptional transactivator. Virology 1992; 187: 663670.
  • 15
    Will H, Cattaneo R, Dardi G, Deinhardt F, Schelkens H, Schaller H. Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. Proc Natl Acad Sci U S A 1985; 82: 891895.
  • 16
    Fuerst TR, Niles E, Studier FW, Moss B. Eukaryotic transient expression system based on recombinant vaccinia virus that synthesizes bacterio-phage T7 RNA polymerase. Proc Natl Acad Sci U S A 1986; 83: 81228126.
  • 17
    Kekulé AS, Lauer U, Weiss L, Luber B, Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 1993; 361: 742745.
  • 18
    Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetylferase in mammalian cells. Mol Cell Biol 1982; 2: 10441051.
  • 19
    Schägger H, v Jagow G. Tricine-sodium dodecyl sulfate polyacrylamide gel electrophoresis for the separation of proteins in the range from 1–100 kDa. Anal Biochem 1987; 166: 368379.
  • 20
    Heukeshoven J, Dernick R. Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis 1985; 6: 103112.
  • 21
    Neurath AR, Kent S, Strick N, Parker K, Courouce A-M, Riotlot M, Petit M, et al. Antibodies to synthetic peptides from the PreS 1 and PreS2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes. Mol Immunol 1987; 24: 975980.
  • 22
    Scully LJ, Kang CJ. Production and secretion of HBsAg and PreS2 plus HBsAg using a baculovirus expression vector. In: ZuckermannAJ, ed. Viral hepatitis and liver disease. New York: Liss, 1988: 365371.
  • 23
    Bachmair A, Varshavsky A. The degradation signal in a short lived protein. Cell 1989; 56: 10191032.